RedditBluesky
  • Home
  • Artificial Intelligence
  • Cryptocurrencies
  • Technology
  • Gold
  • Stocks
Home » News » Bank of America suspends cannabis research firm's account

Bank of America suspends cannabis research firm's account

Despite FDA approval: Cannabis banking remains illegal under federal law

Gabriel ThomasOctober 5, 2026



Bank of America has announced to the Scottsdale Research Institute that it will close its bank account next month, despite the company's cannabis research being sanctioned by the federal government.

In a letter to the Scottsdale Research Institute dated October 12 and posted on social media, Bank of America BAC (+ 1.58%) announced that it will limit banking services within 21 days and close the account by Will finally close on November 12th.

"Bank of America is closing the account of a federally licensed cannabis researcher," said Dr. Sue Sisley on Friday on her Twitter page. "SRI is conducting FDA-approved controlled trials investigating cannabis as a medicine to treat pain / PTSD in military veterans and terminally ill patients, which TRAGICALLY paralyzes our research."

At the time of the last review, the tweet had received 55 comments, mostly criticizing Bank of America. Some people said they would cancel their credit cards at the bank.

A spokesman for the bank contacted by MarketWatch made no comment.

Sisley, a psychiatrist and president of the Scottsdale Research Institute (SRI), added a photo of her U.S. Controlled Substance Registration Certificate to her tweet. Drug Enforcement Administration. The SRI received approval earlier this year after a legal battle with the US government over the right to produce cannabis for medical testing.

According to an article in the cannabis publication Marijuana Moment, the Scottsdale Research Institute is currently reviewing offers from other financial institutions.

"We just wanted to expose the misconduct of these big banks," Sisley told the publication. The Scottsdale Research Institute wants to make it known that even legal businesses are being targeted by those big banks that refuse to see federal agency documents, she said.

Sisley speculated that the Scottsdale Research Institute may have prompted the bank's action by adding psychoactive mushrooms (psilocybin) to its research, but the bank provided "no justification."

The company has openly informed Bank of America about its cannabis use for 10 years. It originally used cannabis from the University of Mississippi for its studies, but was then given the right to grow its own marijuana.

"We have a contract with the DEA. We grow cannabis for clinical trials by the Food and Drug Administration and sell it to the DEA," she said in the Marijuana Moment article. "The way they behave is unscrupulous - and further proof that the word 'cannabis' is still completely contaminated, even though it is a 100% legal operation."

Sisley was fired from the University of Arizona in 2014 after receiving approval from the federal drug agency to study the effects of weed on patients suffering from post-traumatic stress disorder.

In the meantime, cannabis is still on the federal government's list of controlled substances, which in many cases prevents cannabis-related companies from using the banking system. Some banks have served cannabis companies under banking guidelines published during the Obama administration, but the largest U.S. institutions continue to avoid any company or organization that comes into contact with the plant.

Meanwhile, the SAFE banking bill, which aims to open the banking system to cannabis, remains pending in the U.S. Senate after it was recently passed in the U.S. House of Representatives. Cannabis experts don't expect any major moves out of Congress in the near future.

Bank of AmericaForschungUSACannabis





Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.


Claw and Order: Antimony Rules the Resource Realm
Read Next

Claw and Order: Antimony Rules the Resource Realm

  • RIDE THE BULL

    Your Front Row Seat to the Stories That Move Markets. – Subscribe Now to our Newsletter!

  • Trending Now

    • Skyharbour Resources Advances Nasdaq Aspirations with Fresh Athabasca NI 43-101 Filings
      Skyharbour Resources Advances Nasdaq Aspirations with Fresh Athabasca NI 43-101 Filings
    • Amazon Inks 20-Year Deal with Constellation to Expand Clean Nuclear Capacity
      Amazon Inks 20-Year Deal with Constellation to Expand Clean Nuclear Capacity
    • Four for Four: Super Copper Logs Visible Copper at El Alto Target in Atacama
      Four for Four: Super Copper Logs Visible Copper at El Alto Target in Atacama
    • How Ameriwest Is Funding Its Bornite Copper Exploration Through Portfolio Optimization
      How Ameriwest Is Funding Its Bornite Copper Exploration Through Portfolio Optimization

Claim Your Spot with Juniorstocks.com

Unlock the stories that move markets directly in your inbox


ContactDisclaimerData PrivacyTerms of Use
  • Bluesky
  • Reddit
Copyright 2026 ©Juniorstocks.com - All Rights Reserved.